
Volatile Anesthetics for Critical Care Sedation: Clinical Risks and Benefits
Notes de l’épisode
This academic review examines the expanding role of volatile anesthetics, such as isoflurane and sevoflurane, as alternatives to intravenous sedatives in intensive care units. These inhaled agents offer unique pharmacokinetic benefits, including rapid onset and elimination through the lungs, which allows for precise titration and faster recovery independent of liver or kidney function. Modern delivery devices have made these gases more accessible in the ICU, providing potential organ-protective effects and a reduced risk of the withdrawal symptoms associated with traditional drugs like opioids. However, the text also addresses significant safety considerations, noting that while these agents may shorten ventilation time, some data suggest higher mortality risks and a need for specialized monitoring. Ultimately, the authors argue that volatile sedation is a valuable tool for critically ill patients, provided that clinicians manage risks like cardiovascular depression and maintain strict environmental safeguards.
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit iccn.substack.com/subscribe
Tous les épisodes de Interprofessional Critical Care Network (ICCN) Podcast